CN108969444B - Black eye removing, anti-wrinkle firming and repairing eye cream and preparation method thereof - Google Patents
Black eye removing, anti-wrinkle firming and repairing eye cream and preparation method thereof Download PDFInfo
- Publication number
- CN108969444B CN108969444B CN201811093713.1A CN201811093713A CN108969444B CN 108969444 B CN108969444 B CN 108969444B CN 201811093713 A CN201811093713 A CN 201811093713A CN 108969444 B CN108969444 B CN 108969444B
- Authority
- CN
- China
- Prior art keywords
- seed
- eye
- essential oil
- skin
- eye cream
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000006071 cream Substances 0.000 title claims abstract description 74
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 208000035753 Periorbital contusion Diseases 0.000 title claims abstract description 18
- 235000002673 Dioscorea communis Nutrition 0.000 title claims abstract description 17
- 241000544230 Dioscorea communis Species 0.000 title claims abstract description 17
- 230000001153 anti-wrinkle effect Effects 0.000 title claims abstract description 13
- 239000000341 volatile oil Substances 0.000 claims abstract description 56
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 28
- 241000196324 Embryophyta Species 0.000 claims abstract description 27
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 27
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims abstract description 18
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 230000008439 repair process Effects 0.000 claims abstract description 16
- 235000020708 ginger extract Nutrition 0.000 claims abstract description 14
- 229940002508 ginger extract Drugs 0.000 claims abstract description 14
- RTBWWWVNZWFNBV-SFHVURJKSA-N (2s)-3-phenyl-2-(undec-10-enoylamino)propanoic acid Chemical compound C=CCCCCCCCCC(=O)N[C@H](C(=O)O)CC1=CC=CC=C1 RTBWWWVNZWFNBV-SFHVURJKSA-N 0.000 claims abstract description 13
- YFESOSRPNPYODN-RSMWSHJLSA-N (2s,3s,4s,5r,6r)-6-[[(4s,6ar,6bs,8r,8ar,9r,10r,14br)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(z)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3,5-bis[[(2s,3r,4s, Chemical compound O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)OC1CC[C@]2(C)C3CC=C4[C@@]([C@@]3(CCC2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(CC14)(C)C)OC(=O)C(\C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O.O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)OC1CC[C@]2(C)C3CC=C4[C@@]([C@@]3(CCC2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(CC14)(C)C)OC(=O)C(/C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YFESOSRPNPYODN-RSMWSHJLSA-N 0.000 claims abstract description 11
- AXNVHPCVMSNXNP-GKTCLTPXSA-N Aescin Natural products O=C(O[C@H]1[C@@H](OC(=O)C)[C@]2(CO)[C@@H](O)C[C@@]3(C)[C@@]4(C)[C@@H]([C@]5(C)[C@H]([C@](CO)(C)[C@@H](O[C@@H]6[C@@H](O[C@H]7[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)[C@@H](O)[C@H](O[C@H]7[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O7)[C@@H](C(=O)O)O6)CC5)CC4)CC=C3[C@@H]2CC1(C)C)/C(=C/C)/C AXNVHPCVMSNXNP-GKTCLTPXSA-N 0.000 claims abstract description 11
- -1 acetyl chitosamine Chemical compound 0.000 claims abstract description 11
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 9
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000021314 Palmitic acid Nutrition 0.000 claims abstract description 9
- 229940082500 cetostearyl alcohol Drugs 0.000 claims abstract description 9
- 239000008367 deionised water Substances 0.000 claims abstract description 9
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 9
- 235000010445 lecithin Nutrition 0.000 claims abstract description 9
- 239000000787 lecithin Substances 0.000 claims abstract description 9
- 229940067606 lecithin Drugs 0.000 claims abstract description 9
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims abstract description 9
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims abstract description 9
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract description 9
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229960005323 phenoxyethanol Drugs 0.000 claims abstract description 9
- 229940032094 squalane Drugs 0.000 claims abstract description 9
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims abstract description 9
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims abstract description 9
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims abstract description 6
- 240000007154 Coffea arabica Species 0.000 claims abstract description 6
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229940084052 syzygium jambos leaf extract Drugs 0.000 claims abstract description 6
- UITSPQLTFPTHJZ-UHFFFAOYSA-N 2-[[3,4,5-tris(2-hydroxyethoxy)-6-methoxyoxan-2-yl]methoxy]ethanol Chemical compound COC1OC(COCCO)C(OCCO)C(OCCO)C1OCCO UITSPQLTFPTHJZ-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229940100485 methyl gluceth-10 Drugs 0.000 claims abstract description 4
- 229940098695 palmitic acid Drugs 0.000 claims abstract description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims abstract description 3
- 239000000843 powder Substances 0.000 claims description 32
- 239000002502 liposome Substances 0.000 claims description 27
- 238000003756 stirring Methods 0.000 claims description 24
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 22
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 18
- 239000003921 oil Substances 0.000 claims description 16
- 230000037303 wrinkles Effects 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 13
- 241000984090 Cistus Species 0.000 claims description 12
- 235000002548 Cistus Nutrition 0.000 claims description 12
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 238000009472 formulation Methods 0.000 claims description 12
- 229930003427 Vitamin E Natural products 0.000 claims description 11
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 11
- 235000019165 vitamin E Nutrition 0.000 claims description 11
- 229940046009 vitamin E Drugs 0.000 claims description 11
- 239000011709 vitamin E Substances 0.000 claims description 11
- 240000008620 Fagopyrum esculentum Species 0.000 claims description 10
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 10
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims description 10
- 241000219925 Oenothera Species 0.000 claims description 10
- 235000004496 Oenothera biennis Nutrition 0.000 claims description 10
- 240000002503 Vitis amurensis Species 0.000 claims description 10
- 235000004283 Vitis amurensis Nutrition 0.000 claims description 10
- 239000002245 particle Substances 0.000 claims description 10
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 9
- 235000006647 Eugenia jambos Nutrition 0.000 claims description 9
- 244000087016 Syzygium jambos Species 0.000 claims description 9
- 229940076810 beta sitosterol Drugs 0.000 claims description 9
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims description 9
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 claims description 9
- 229940107161 cholesterol Drugs 0.000 claims description 9
- 235000012000 cholesterol Nutrition 0.000 claims description 9
- 229940099578 hydrogenated soybean lecithin Drugs 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 claims description 9
- 229950005143 sitosterol Drugs 0.000 claims description 9
- 235000011187 glycerol Nutrition 0.000 claims description 8
- 229940087559 grape seed Drugs 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 6
- 230000001804 emulsifying effect Effects 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 238000003801 milling Methods 0.000 claims description 6
- 239000011812 mixed powder Substances 0.000 claims description 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 6
- 229920000053 polysorbate 80 Polymers 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- 229940104261 taurate Drugs 0.000 claims description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 6
- 240000004658 Medicago sativa Species 0.000 claims description 4
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- 238000007599 discharging Methods 0.000 claims description 3
- 235000019441 ethanol Nutrition 0.000 claims description 3
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 238000006703 hydration reaction Methods 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 230000010355 oscillation Effects 0.000 claims description 3
- 230000002633 protecting effect Effects 0.000 claims description 3
- 238000005086 pumping Methods 0.000 claims description 3
- 238000002390 rotary evaporation Methods 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- UITSPQLTFPTHJZ-XTLGRWLVSA-N 2-[[(2r,6r)-3,4,5-tris(2-hydroxyethoxy)-6-methoxyoxan-2-yl]methoxy]ethanol Chemical compound CO[C@@H]1O[C@H](COCCO)C(OCCO)C(OCCO)C1OCCO UITSPQLTFPTHJZ-XTLGRWLVSA-N 0.000 claims description 2
- 229920001503 Glucan Polymers 0.000 claims description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 2
- 235000011152 sodium sulphate Nutrition 0.000 claims description 2
- 240000001398 Typha domingensis Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 36
- 239000008187 granular material Substances 0.000 abstract description 5
- 238000009499 grossing Methods 0.000 abstract description 4
- 238000005562 fading Methods 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 240000002022 Anthriscus cerefolium Species 0.000 abstract 1
- 235000007258 Anthriscus cerefolium Nutrition 0.000 abstract 1
- 229960005150 glycerol Drugs 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 66
- 238000012360 testing method Methods 0.000 description 29
- 230000000052 comparative effect Effects 0.000 description 22
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 20
- 206010040954 Skin wrinkling Diseases 0.000 description 12
- 241000723377 Coffea Species 0.000 description 11
- 102000008186 Collagen Human genes 0.000 description 8
- 108010035532 Collagen Proteins 0.000 description 8
- 229920001436 collagen Polymers 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 7
- 241000219823 Medicago Species 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 230000037394 skin elasticity Effects 0.000 description 6
- 210000004177 elastic tissue Anatomy 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 240000000451 Zingiber zerumbet Species 0.000 description 4
- 235000014687 Zingiber zerumbet Nutrition 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 102000016942 Elastin Human genes 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000002808 connective tissue Anatomy 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- 210000000744 eyelid Anatomy 0.000 description 3
- 210000002752 melanocyte Anatomy 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 208000035484 Cellulite Diseases 0.000 description 2
- 235000007460 Coffea arabica Nutrition 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010049752 Peau d'orange Diseases 0.000 description 2
- 206010034719 Personality change Diseases 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000036232 cellulite Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000036074 healthy skin Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000000106 sweat gland Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- AXNVHPCVMSNXNP-OXPBSUTMSA-N Aescin Chemical compound O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(C[C@H]14)(C)C)OC(=O)C(\C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O AXNVHPCVMSNXNP-OXPBSUTMSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 102100029133 DNA damage-induced apoptosis suppressor protein Human genes 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 101000918646 Homo sapiens DNA damage-induced apoptosis suppressor protein Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- IQZUZPKOFSOVET-CMDGGOBGSA-N Isobutyl cinnamate Chemical compound CC(C)COC(=O)\C=C\C1=CC=CC=C1 IQZUZPKOFSOVET-CMDGGOBGSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- 102100034216 Melanocyte-stimulating hormone receptor Human genes 0.000 description 1
- 101710161100 Melanocyte-stimulating hormone receptor Proteins 0.000 description 1
- 206010027146 Melanoderma Diseases 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- HIGQPQRQIQDZMP-DHZHZOJOSA-N Neryl acetate Natural products CC(C)=CCC\C(C)=C\COC(C)=O HIGQPQRQIQDZMP-DHZHZOJOSA-N 0.000 description 1
- ZSBOMYJPSRFZAL-RAXLEYEMSA-N Neryl butyrate Chemical compound CCCC(=O)OC\C=C(\C)CCC=C(C)C ZSBOMYJPSRFZAL-RAXLEYEMSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 235000000664 Rosa chinensis Nutrition 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 240000000260 Typha latifolia Species 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 206010047141 Vasodilatation Diseases 0.000 description 1
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940011399 escin Drugs 0.000 description 1
- 229930186222 escin Natural products 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- HIGQPQRQIQDZMP-UHFFFAOYSA-N geranil acetate Natural products CC(C)=CCCC(C)=CCOC(C)=O HIGQPQRQIQDZMP-UHFFFAOYSA-N 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 108091008039 hormone receptors Proteins 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- HIGQPQRQIQDZMP-FLIBITNWSA-N neryl acetate Chemical compound CC(C)=CCC\C(C)=C/COC(C)=O HIGQPQRQIQDZMP-FLIBITNWSA-N 0.000 description 1
- RJIWZDNTCBHXAL-UHFFFAOYSA-N nitroxoline Chemical compound C1=CN=C2C(O)=CC=C([N+]([O-])=O)C2=C1 RJIWZDNTCBHXAL-UHFFFAOYSA-N 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000036619 pore blockages Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
components | Group A | Group B | Group C |
Evening primrose seed | 22.2g | 16.7g | 18.2g |
Vitis amurensis seed | 22.2g | 16.7g | 36.4g |
Alfalfa seeds | 11.2g | 16.7g | 9.0g |
Buckwheat seed | 44.4g | 49.9g | 36.4g |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811093713.1A CN108969444B (en) | 2018-09-19 | 2018-09-19 | Black eye removing, anti-wrinkle firming and repairing eye cream and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811093713.1A CN108969444B (en) | 2018-09-19 | 2018-09-19 | Black eye removing, anti-wrinkle firming and repairing eye cream and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108969444A CN108969444A (en) | 2018-12-11 |
CN108969444B true CN108969444B (en) | 2021-02-02 |
Family
ID=64545695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811093713.1A Active CN108969444B (en) | 2018-09-19 | 2018-09-19 | Black eye removing, anti-wrinkle firming and repairing eye cream and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108969444B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111759774A (en) * | 2020-08-17 | 2020-10-13 | 刘婷 | Whitening anti-wrinkle essence |
CN111991286A (en) * | 2020-08-20 | 2020-11-27 | 上海致新生物科技有限公司 | Eye cream composition for fading fine wrinkles and preparation method thereof |
CN112220714A (en) * | 2020-09-11 | 2021-01-15 | 广州多美生物科技有限公司 | Red ginseng vigor activating oxygen eye cream and preparation method thereof |
CN112190512A (en) * | 2020-11-02 | 2021-01-08 | 武汉润禾生物医药有限公司 | Preparation method and application of eye cream with remarkable curative effect on dark eye circles and under-eye puffiness |
CN113893215B (en) * | 2021-10-09 | 2023-08-08 | 广州市涵美化妆品有限公司 | Eye tightening and repairing composition, application and eye cream and preparation method thereof |
CN113797136A (en) * | 2021-10-27 | 2021-12-17 | 北京旋光普利生物医药科技开发有限公司 | Combined preparation of anti-wrinkle-reducing eye cream emulsion |
CN114224779A (en) * | 2021-12-27 | 2022-03-25 | 广州睿森生物科技有限公司 | Eye repair composition and application thereof |
CN114209640B (en) * | 2022-01-27 | 2023-12-08 | 上海澄穆生物科技有限公司 | Anti-aging skin care product composition and preparation method thereof |
CN115813795A (en) * | 2022-12-30 | 2023-03-21 | 泉后(广州)生物科技研究院有限公司 | Anti-wrinkle composition and application thereof |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2422107A (en) * | 2004-12-23 | 2006-07-19 | Boots Co Plc | Skin whitening composition |
WO2007078060A1 (en) * | 2005-12-30 | 2007-07-12 | Amorepacific Corporation | Polymer-liposome nano-complexes and the preparation method thereof, and the composition of skin external application containing the same |
WO2007133768A3 (en) * | 2006-05-15 | 2008-01-10 | Procter & Gamble | Method of enhancing penetration of water-soluble actives |
WO2008087591A1 (en) * | 2007-01-16 | 2008-07-24 | The Procter & Gamble Company | Cosmetic compositions |
CN102379834A (en) * | 2011-10-31 | 2012-03-21 | 上海交通大学 | Scent plant extractive for comprehensively conditioning skin around eyes and eye care product thereof |
CN103393581A (en) * | 2013-08-15 | 2013-11-20 | 江南大学 | Natural anti-wrinkling anti-aging skin care composition and application thereof in cosmetic |
CN103655412A (en) * | 2013-11-20 | 2014-03-26 | 青岛晨讯通商贸有限公司 | Improved eye cream |
CN103876982A (en) * | 2014-03-24 | 2014-06-25 | 烟台新时代健康产业日化有限公司 | Nano-liposome emulsion and preparation method thereof |
CN104800119A (en) * | 2015-04-21 | 2015-07-29 | 长江大学 | Lavender essential oil liposome and preparation method thereof |
CN105055480A (en) * | 2015-08-10 | 2015-11-18 | 江苏大学 | Curry plant essential oil nano-liposome antibacterial agent, and preparation method thereof |
CN105287264A (en) * | 2015-11-25 | 2016-02-03 | 上海赢嘉实业有限公司 | Preparation method and uses of aromatic oil complex encapsulation liposome |
CN105411986A (en) * | 2015-12-25 | 2016-03-23 | 北京百生康生物科技有限公司 | Firming antiwrinkle eye gel |
CN106983700A (en) * | 2017-03-29 | 2017-07-28 | 北海市宝珠林海洋科技有限公司 | One kind effectively removes black-eyed eye cream |
CN108478476A (en) * | 2018-05-22 | 2018-09-04 | 佛山云裳化妆品有限公司 | One kind is dispelled livid ring around eye composition and eye cream |
-
2018
- 2018-09-19 CN CN201811093713.1A patent/CN108969444B/en active Active
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2422107A (en) * | 2004-12-23 | 2006-07-19 | Boots Co Plc | Skin whitening composition |
WO2007078060A1 (en) * | 2005-12-30 | 2007-07-12 | Amorepacific Corporation | Polymer-liposome nano-complexes and the preparation method thereof, and the composition of skin external application containing the same |
WO2007133768A3 (en) * | 2006-05-15 | 2008-01-10 | Procter & Gamble | Method of enhancing penetration of water-soluble actives |
WO2008087591A1 (en) * | 2007-01-16 | 2008-07-24 | The Procter & Gamble Company | Cosmetic compositions |
CN102379834A (en) * | 2011-10-31 | 2012-03-21 | 上海交通大学 | Scent plant extractive for comprehensively conditioning skin around eyes and eye care product thereof |
CN103393581A (en) * | 2013-08-15 | 2013-11-20 | 江南大学 | Natural anti-wrinkling anti-aging skin care composition and application thereof in cosmetic |
CN103655412A (en) * | 2013-11-20 | 2014-03-26 | 青岛晨讯通商贸有限公司 | Improved eye cream |
CN103876982A (en) * | 2014-03-24 | 2014-06-25 | 烟台新时代健康产业日化有限公司 | Nano-liposome emulsion and preparation method thereof |
CN104800119A (en) * | 2015-04-21 | 2015-07-29 | 长江大学 | Lavender essential oil liposome and preparation method thereof |
CN105055480A (en) * | 2015-08-10 | 2015-11-18 | 江苏大学 | Curry plant essential oil nano-liposome antibacterial agent, and preparation method thereof |
CN105287264A (en) * | 2015-11-25 | 2016-02-03 | 上海赢嘉实业有限公司 | Preparation method and uses of aromatic oil complex encapsulation liposome |
CN105411986A (en) * | 2015-12-25 | 2016-03-23 | 北京百生康生物科技有限公司 | Firming antiwrinkle eye gel |
CN106983700A (en) * | 2017-03-29 | 2017-07-28 | 北海市宝珠林海洋科技有限公司 | One kind effectively removes black-eyed eye cream |
CN108478476A (en) * | 2018-05-22 | 2018-09-04 | 佛山云裳化妆品有限公司 | One kind is dispelled livid ring around eye composition and eye cream |
Also Published As
Publication number | Publication date |
---|---|
CN108969444A (en) | 2018-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108969444B (en) | Black eye removing, anti-wrinkle firming and repairing eye cream and preparation method thereof | |
US9272012B1 (en) | Herbal skin care composition | |
KR102265730B1 (en) | cosmetic composition for skin wrinkle improvement and whitening facial skin | |
CN111166683A (en) | Fullerene anti-aging antioxidant beauty and skin care cosmetic and preparation method thereof | |
JP7309620B2 (en) | Use of an extract of pericarp of NEPHELIUM LAPPACEUM for hydrating skin and/or mucous membranes | |
CN109044941B (en) | Skin firming, nourishing and moisturizing composition and preparation method and application thereof | |
WO2020033450A1 (en) | Wrinkle reducing compositions and methods | |
CN110302091B (en) | Composition containing nicotinamide adenine dinucleotide for resisting skin aging and preparation method and application thereof | |
CN113876665B (en) | Face cream composition with anti-wrinkle effect and preparation method and application thereof | |
JP2010241762A (en) | Cosmetic | |
CN111434332A (en) | Nourishing and repairing emulsion and preparation method thereof | |
EP2596787B1 (en) | New use of hesperetin | |
CN109363977A (en) | Clear CC frost of a kind of moist water profit and preparation method thereof | |
WO2014094377A1 (en) | Bee venom composition with effects of protecting and beautifying lip | |
JP2022534485A (en) | Skin therapeutic compositions and preservative systems | |
CN113893199B (en) | A facial cream composition with effect of increasing skin thickness and its preparation method | |
FR3033699A1 (en) | EXTRACT OF CHINA PEPPER, COMPOSITION COMPRISING SAID EXTRACT AND COSMETIC USE | |
CN111700847B (en) | Composition for treating dark eye circles by synergistic laser, eye essence and preparation method | |
CN115887264A (en) | Liponic acid combined fullerene liposome, essence and preparation method thereof | |
CN111065375A (en) | Cosmetic composition for antioxidation and reducing atopy comprising fermented soybean milk | |
CN111773151B (en) | Whitening and freckle-removing antioxidant emulsion and preparation method thereof | |
CN113730295A (en) | Essence emulsion composition containing lipid nanoparticles with wrinkle-removing and tightening effects and preparation method thereof | |
KR101436819B1 (en) | Cosmetic composition for moisturing, soothing skin and improving acne | |
KR20120138382A (en) | Pack composition | |
CN112315866A (en) | Black plant extract and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210119 Address after: 266109 room 306, building 18, shuiyuecheng, Zhengyang Road, Chengyang street, Chengyang District, Qingdao City, Shandong Province Applicant after: Qingdao shengkangsheng Biotechnology Co.,Ltd. Address before: Shop 6, jingcui building, 17 Yangmei Hexi Road, Yanghe Town, Gaoming District, Foshan City, Guangdong Province, 528515 Applicant before: Chen Jiezhen |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240327 Address after: Room 407, Branch No. 183 Zhengyang Road, Chengyang District, Qingdao City, Shandong Province, 266000 Patentee after: Shengyi Traditional Chinese Medicine Innovation Research Co.,Ltd. Country or region after: China Address before: 266109 room 306, building 18, shuiyuecheng, Zhengyang Road, Chengyang street, Chengyang District, Qingdao City, Shandong Province Patentee before: Qingdao shengkangsheng Biotechnology Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |